An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

Recruiting Phase 2 Interventional Study
Tobacco Use Disorder
Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Basic Science
Participants needed
30 (estimated)
Sponsor
University of Missouri-Columbia · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Entry criteria: Inclusion Criteria all subjects: 1. Age 18-65 years 2. English fluency 3. Functional vision (with corrective lenses as needed) to complete assigned assessments and tasks 4. Smoke \> 10 cigarettes/day for a minimum of 2 yrs. and have an expired carbon monoxide (CO) concentration of …
Contacts

Madhura Athreya, MS

573-882-2977

athreyam@health.missouri.edu

CONTACT

Brett E Froeliger, PhD

573-882-4785

froeligerb@health.missouri.edu

CONTACT